GLAXO
Invest Now
GlaxoSmithKline Pharmaceuticals Share Price
₹2,381.35 -56.65 (-2.32%)
21 Nov, 2024 14:25
Start SIP in GLAXO
Start SIPPerformance
- Low
- ₹2,373
- High
- ₹2,450
- 52 Week Low
- ₹1,577
- 52 Week High
- ₹3,088
- Open Price₹2,438
- Previous Close₹2,438
- Volume50,758
Investment Returns
- Over 1 Month -10.45%
- Over 3 Month -17.66%
- Over 6 Month + 0.92%
- Over 1 Year + 44.5%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 59.8
- PEG Ratio
- 14.2
- Market Cap Cr
- 40,342
- P/B Ratio
- 22.7
- Average True Range
- 86.08
- EPS
- 47.33
- Dividend Yield
- 1.8
- MACD Signal
- -48.43
- RSI
- 33.94
- MFI
- 44.81
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,381.35
-56.65
(-2.32%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹2,567.47
- 50 Day
- ₹2,642.41
- 100 Day
- ₹2,621.75
- 200 Day
- ₹2,447.87
Resistance and Support
2443.5
- R3 2,537.35
- R2 2,507.90
- R1 2,472.95
- S1 2,408.55
- S2 2,379.10
- S3 2,344.15
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,381 As on 21 November, 2024 | 14:11
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹40341.5 Cr As on 21 November, 2024 | 14:11
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 59.8 As on 21 November, 2024 | 14:11
The PB ratio of GlaxoSmithKline Pharmaceuticals is 22.7 As on 21 November, 2024 | 14:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.